- The Problem
- Crop diseases and toxins cause over $220 billion in global losses annually. Traditional chemical fungicides are losing efficacy and face mounting regulatory, environmental, and consumer scrutiny.
Genvor merges biology and machine learning to deliver sustainable peptides that enhance crop protection, reduce environmental impact, and improve nutrition.
Core Technologies
AMPS, CEPs, NEPs & Insecticidal
At the heart of our innovation are four proprietary peptide classes engineered for high-impact applications in plant health, animal feed, and sustainable agriculture.
Elevating Agricultural Performance Through Peptide Science
- The Market Shift
- Agriculture is entering a pivotal transition toward biological innovation. Demand for cleaner, more sustainable, and residue-free inputs is accelerating in response to shifting regulations, environmental constraints, and consumer expectations.
- The Solution
- Genvor’s patented peptides offer a powerful alternative to synthetic crop protection. Designed to work with the plant’s natural immune system, these biodegradable peptides are highly selective, residue-free, and compatible with a range of crops through foliar applications and trait integration.
- Validation
- Genvor’s technology has advanced through rigorous lab, greenhouse, and early-stage field testing—particularly in corn and citrus—supported by longstanding USDA collaboration and aligned with regulatory pathways.
- Intellectual Property
- Our innovation engine is safeguarded by a growing IP portfolio, including two issued U.S. patents and a third pending, covering 24 proprietary peptides across multiple use cases with thousands of peptides within the company's library.
- Business Model
- We follow a capital-efficient licensing model, enabling broad adoption through partnerships with leading agricultural companies while focusing internal efforts on scientific development and platform expansion.
- Addressable Market
- Genvor is positioned to lead within the $250B+ global ag input market as a scalable, science-driven provider of sustainable biological solutions for crop protection and nutrient efficiency.
BioCypher Algorithm
AI-Powered Peptide Design for Commercial Success
At the core of Genvor’s proprietary peptide platform is the BioCypher Algorithm, an AI-driven system that combines computational biology with machine learning to accelerate peptide discovery while ensuring commercial viability across diverse crop environments. By integrating molecular modeling, predictive analytics, and regulatory benchmarks, our platform accelerates peptide discovery faster than traditional R&D approaches.
Predictive Modeling
Designing High-Performance Peptides
BioCypher utilizes advanced molecular simulation techniques to predict how peptides interact with biological targets, enabling:
- Structure-function mapping
- AI models analyze molecular structures to predict binding efficiency and stability.
- Bioactivity refinement
- Predicts how peptides fight pathogens, boost nutrient uptake, and regulate metabolism.
- Environmental adaptability
- Simulates peptide performance across soils, climates, and microbial environments.
Peptide Optimization
AI-Driven Molecular Engineering
Through iterative learning, BioCypher enhances peptide efficacy using:
- Reinforcement learning models
- Trains algorithms to find peptides with ideal stability and bioavailability.
- Evolutionary algorithms
- Applies natural selection to refine peptide sequences for better performance.
- Cross-crop adaptability analysis
- Optimizes peptides for various crops to support scalable use.
Machine Learning Capabilities
Accelerating Innovation at Scale
BioCypher continuously evolves through large-scale peptide datasets, improving predictions over time by:
- High-throughput screening
- AI-generated libraries rapidly test peptide bioactivity across scenarios.
- Data-driven precision farming
- Uses field data to refine peptide strategies and crop integration.
- Regulatory-informed AI modeling
- Builds in USDA/EPA benchmarks to boost market readiness.
Market Opportunity
Proven Science, Protected Technology
Our innovations are protected by a robust and expanding IP portfolio including 5 issued U.S. patents covering antimicrobial and nutrient-enhancing peptides, with 2 pending U.S. applications and 4 additional applications in preparation. International filings in Canada, Mexico, and China protect our technology in key agricultural markets through 2038. With 50,000+ designed peptides and 24 proprietary peptides in our active library, we’ve created a platform built for global impact through licensing-first commercialization. Notable validation includes our transgenic corn peptide AGM182, developed in collaboration with the USDA, which achieved 72% reduction in fungal growth and 98% reduction in aflatoxin in trials, demonstrating commercial-grade performance with regulatory pathway clarity.
Real-World Impact
Tested & Validated
Field Trials at USDA-Managed Sites
Genvor’s peptide-enhanced corn hybrids are in USDA field trials, generating real-world data to support commercial readiness.
Built-In Regulatory Advantage
3x Faster EPA Registration
Early USDA engagement allows Genvor’s biochemicals to secure EPA approval up to 3x faster, accelerating market entry.
Ready for Strategic Partnership
6+ Tier-1 Ag Industry Players
Genvor is in talks with over six Tier-1 ag players, using a licensing-first model to enable scalable, strategic partnerships.
Let’s Grow the Future Together
Genvor is already in talks with 6+ top-tier ag industry leaders—our licensing-first model is built for real-world deployment and long-term success.
Interested in partnering? Let’s talk.
Email: licensing@genvor.com
Phone: (715)-903-6473